Concepedia

Paul Coluzzi

PC

13

Publications

1.7K

Citations

11

H-Index

1995

Active since

Affiliations

City Of Hope National Medical Center(Current)

Mount Sinai Beth Israel

City of Hope

Memorial Sloan Kettering Cancer Center

Missouri Baptist Medical Center

Paul Coluzzi is an author at City Of Hope National Medical Center specializing in pharmacology, medicine, and oncology.

Top concepts

Publications per year

1995–2023

13

Publications

13

A Phase II Study of Pembrolizumab in EGFR-Mutant, PD-L1+, Tyrosine Kinase Inhibitor Naïve Patients With Advanced NSCLC

Aaron Lisberg, Amy L. Cummings, Jonathan W. Goldman et al. · Journal of Thoracic Oncology · 2018 · 577 citations · Full text

, , +7

Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC®) and morphine sulfate immediate release (MSIR®)

Paul Coluzzi, Lee S. Schwartzberg, John D. Conroy et al. · Pain · 2001 · 335 citations

, , +18

Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study

Russell K. Portenoy, Richard Payne, Paul Coluzzi et al. · Pain · 1999 · 240 citations

Dose-titration, multicenter study of oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients using transdermal fentanyl for persistent pain.

Joan M. Christie, Mary A. Simmonds, Richard B. Patt et al. · Journal of Clinical Oncology · 1998 · 178 citations

Long-Term Safety of Oral Transmucosal Fentanyl Citrate for Breakthrough Cancer Pain

Richard Payne, Paul Coluzzi, Lowell L. Hart et al. · Journal of Pain and Symptom Management · 2001 · 99 citations · Full text

, , +13

Rows per page

1–5 of 13